Atlas Trials

A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers

Clinical trial NCT00231829 · TERMINATED

Trial details

NCT number
NCT00231829
Sponsor
Mark H. Einstein
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Uterine Cancer
Start date
2003-04-01
Primary completion
2004-03-01
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.